Do the effects of psychological treatments on improving glycemic control in type 1 diabetes persist over time? A long-term follow-up of a randomized controlled trial

Psychosomatic Medicine

Volumn 74, Issue 3, 2012, Pages 319-323

  Ridge, Katie ^a   Bartlett, Jonathan ^b   Cheah, Yee ^a   Thomas, Stephen ^c   Lawrence Smith, Geoffrey ^d   Winkley, Kirsty ^a   Ismail, Khalida ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d OXLEAS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

long term follow up; randomized controlled trial; suboptimal glycemic control; type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; COGNITIVE THERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PRIORITY JOURNAL; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; MALE; MOTIVATION; NURSING CARE; PATIENT COMPLIANCE; SELF CARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859718106     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31824c181b     Document Type: Article

References (31)

1. National Diabetes Audit. Key findings about the quality of care for people with diabetes in England and Wales Report for the audit period 2007-2008; 2008. Available at: http://www.ic.nhs.uk/diabetesaudits. Accessed October 5, 2010.
2. NICE. Type 1 diabetes in children, young people and adults. Clinical Guideline (CG15). London, UK: National Institute for Health and Clinical Excellence, 2010. Available at: http://www.nice.org.uk/guidance/CG15. Accessed October 5, 2010.
3. Das-Munshi J, Stewart R, Ismail K, Bebbington P, Jenkins R, Prince M. Diabetes, common mental disorders and disability: findings from the UK National Psychiatric Morbidity Survey. Psychosom Med 2007;69:543-50. (Pubitemid 47205738)
4. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney R, Clause R. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934-42. (Pubitemid 30480020)
5. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson A. Assessment of diabetes-specific distress. Diabetes Care 1995;18:754-60.
6. Anderson R, Freedland K, Clouse R, Lustman P. The prevalence of co morbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78. (Pubitemid 33716379)
7. Colton P, Olmsted M, Daneman D, Rydall A, Rodin G. Five year prevalence and persistence of disturbed eating behavior and eating disorders in girls with Type 1 diabetes. Diabetes Care 2007;30:2861-2. (Pubitemid 350083135)
8. Polonsky W. Emotional and quality of life aspects of diabetes management. Curr Diab Rep 2002;2:153-9.
9. Mollema ED, Snoek FJ, Power F, van der Ploeg HM. Diabetes fear of injecting and self testing questionnaire. Diabetes Care 2000;23:765-9. (Pubitemid 30414190)
10. National service framework for diabetes: standards. Health Service Circular (HSC 2001/026). London, UK: Department of Health. Available at: http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/ Healthservicecirculars/DH-4004515. Accessed February 1, 2011.
11. Beck A. Cognitive Therapy and the Emotional Disorders. New York, NY: Meridian; 1976.
12. Miller W, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. 2nd ed. New York, NY: Guilford Press; 2002.
13. Winkley K, Landau S, Eisler I, Ismail K. Psychological interventions to improve glycemic control in patients with Type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ 2006;333:65-70.
14. Alam R, Sturt J, Lall R, Winkley K. An updated meta-analysis to assess the effectiveness of psychological interventions delivered by psychological specialists and specialist clinicians on glycemic control and on psychological status. Patient Educ Couns 2009;75:25-36.
15. Ismail K, Thomas S, Maissi E, Chalder T, Schmidt U, Bartlett J, Patel A, Dickens C, Creed F, Treasure J. Motivational enhancement therapy with and without cognitive behavioral therapy to treat Type 1 diabetes: a randomized control trial. Ann Intern Med 2008;149:708-19.
16. Nansel TR, Plotnick LP, Iannotti RJ, Clark LM, Simons-Morton B, Zeitzoff L. Long-term maintenance of treatment outcomes: diabetes personal trainer intervention for youth with Type 1 diabetes. Diabetes Care 2009;32:807-9.
17. Ellis D, Templin T, Naar-King S, Frey M, Cunningham P, Sheidow A, Cakan N, Idalsky A. Multisystemic therapy for adolescents with poorly controlled Type 1 diabetes: reduced diabetic ketoacidosis admissions and related costs over 24 months. Diabetes Care 2008;31:1746-7.
18. Maissi E, Ridge K, Treasure J, Chalder T, Roche S, Bartlett J, Schmidt U, Thomas S, Ismail K. Nurse-led psychological interventions to improve diabetes control: assessing competencies. Patient Educ Couns 2011;84:e37-43.
19. Beunckens C, Molenberghs G, Kenward M. Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials. Clin Trials 2005;2:379-86. (Pubitemid 41586022)
20. Nathan D, Cleary P, Backlund J, Genuth S, Lachin J, Orchard T, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with Type 1 diabetes. N Engl J Med 2005;353:2643-53. (Pubitemid 41817713)
21. Speight J, Amiel S, Bradley C, Heller S, Oliver L, Roberts S, Taylor C, Thompson G. Long term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment for Normal Eating) structured education to promote intensive insulin therapy in adults with sub optimally controlled diabetes. Diabetes Res Clin Pract 2010;80:22-9.
22. Amiel S, Beveridge S, Bradley C, Gianfrancesco C, Heller S, James P, McKeown N. Training in flexible intensive insulin management to enable dietary freedom: Dose Adjustment for Normal Eating (DAFNE) randomised controlled trial. BMJ 2002;325:746-52.
23. Satin W, La Greca A, Zigo M, Skyler J. Diabetes in adolescence: effects of multifamily group intervention and parent simulation of diabetes. J Pediatr Psychol 1989;14:259-75. (Pubitemid 19165672)
24. Didjurgeit U, Kruse J, Schmitz N, Stuckenschnieder P, Sawicki P. A time-limited, problem-orientated psychotherapeutic intervention in Type 1 diabetic patients with complications: a randomized controlled trial. Diabet Med 2002;19:814-21. (Pubitemid 35177179)
25. Amsberg S, Anderbro T, Wredling R, Lisspers J, Lins P-E, Adamson U. A cognitive behavior therapy-based intervention among poorly controlled adult Type 1 diabetes patients: a randomized controlled trial. Patient Educ Couns 2009;77:72-80.
26. A1c moderated by depression. A randomized controlled trial. Diabet Med 2008;25:1337-42.
27. Surwit R, van Tilburg M, Zucker N, McCaskill C, Parekh P, Feinglos M. Stress management improves long-term glycemic control in Type 2 diabetes. Diabetes Care 2002;25:30-4. (Pubitemid 41070779)
28. Edge J, Ford-Adams M, Dunger D. Causes of death in children with insulin dependent diabetes 1990-1996. Arch Dis Child 1999;81:318-23. (Pubitemid 29467769)
29. Samuel-Hodge CD, Keyserling TC, Park S, Johnston L, Gizlice Z, Bangdiwala S. A randomized trial of a church-based diabetes self-management program for African Americans with Type 2 diabetes. Diabetes Educ 2009;35:439-54.
30. Grasel E, Schmidt R, Biehler J, Schupp W. Long term effects of the intensification of the transition between inpatient and neurological rehabilitation and home care of stroke patients. Clin Rehabil 2006;20:577-83. (Pubitemid 44193030)
31. Maxion-Bergemann S, Huppertz E, Jacobs L, Muller E, Walleser S. Improved glycemic control with decreased hypoglycemia prevents long-term complications in Type 2 diabetes patients: long-term simulation analysis using the "diabetes mellitus model". Int J Clin Pharmacol Ther 2005;43:271-81. (Pubitemid 40872614)